Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Durrant

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Anti-Cancer Drugs|December 13, 1997
Cancer vaccinesL G Durrant
Journal of Immunological Methods|February 14, 1992
A rapid method for separating tumour infiltrating cells and tumour cells from colorectal tumoursL G Durrant
Expert Opinion on Emerging Drugs|December 10, 2003
Cancer vaccines entering Phase III clinical trialsL G Durrant, I Spendlove
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2002
Immunization against tumor cell surface complement-regulatory proteinsL G Durrant, I Spendlove
QJM : Monthly Journal of the Association of Physicians|September 1, 1996
Cancer vaccinesL G Durrant, I Spendlove
Chemico-Biological Interactions|February 1, 1982
Potentiation of cell killing by inhibitors of poly(ADP-ribose) polymerase in four rodent cell lines exposed to N-methyl-N-nitrosourea or UV lightL G Durrant, J M Boyle
Expert Opinion on Biological Therapy|June 7, 2005
Development of cancer vaccines to activate cytotoxic T lymphocytesL G Durrant, J M Ramage
Methods in Molecular Medicine|March 2, 2011
Cancer vaccinesL G Durrant, T J Buckley
Tissue Antigens|November 26, 2002
The role of CD55 in protecting the tumour environment from complement attackJ Morgan, I Spendlove, L G Durrant
Clinical and Experimental Immunology|January 13, 2012
Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapyL G Durrant, P Noble, I Spendlove
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Anti-Cancer Drugs|December 13, 1997
Cancer vaccinesL G Durrant
Journal of Immunological Methods|February 14, 1992
A rapid method for separating tumour infiltrating cells and tumour cells from colorectal tumoursL G Durrant
Expert Opinion on Emerging Drugs|December 10, 2003
Cancer vaccines entering Phase III clinical trialsL G Durrant, I Spendlove
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2002
Immunization against tumor cell surface complement-regulatory proteinsL G Durrant, I Spendlove
QJM : Monthly Journal of the Association of Physicians|September 1, 1996
Cancer vaccinesL G Durrant, I Spendlove
Chemico-Biological Interactions|February 1, 1982
Potentiation of cell killing by inhibitors of poly(ADP-ribose) polymerase in four rodent cell lines exposed to N-methyl-N-nitrosourea or UV lightL G Durrant, J M Boyle
Expert Opinion on Biological Therapy|June 7, 2005
Development of cancer vaccines to activate cytotoxic T lymphocytesL G Durrant, J M Ramage
Methods in Molecular Medicine|March 2, 2011
Cancer vaccinesL G Durrant, T J Buckley
Tissue Antigens|November 26, 2002
The role of CD55 in protecting the tumour environment from complement attackJ Morgan, I Spendlove, L G Durrant
Clinical and Experimental Immunology|January 13, 2012
Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapyL G Durrant, P Noble, I Spendlove
Pageof 9